1-(4-methylbenzo[d]thiazol-2-yl)azetidin-3-ol, 95.0%, 2.5g

1-(P-Methoxyphenyl)-1-buten-3-one, 95.0%, 250mg

Solution de modification de la matrice de nitrate de palladium, 5 g/l Pd(NO3)2 (99,999 %) dans 1 % HNO3

4-Chloro-3-(3-chlorophenyl)-5,6H-pyradazin-6-one, 95.0%, 10g

1,3,5-Tris(pyrazol-4-yl)benzene, 95%, 5g

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine, 95.0%, 1g

5-Hydroxy-2-methyl-piperidine-1-carboxylic acid benzyl ester, 98+%, 500mg

Gb5 Ceramide>95.0%(HPLC)5mg

3-Amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one, 95.0%, 250mg

(S)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide, 95.0%, 10g

2-CHLORO-3,5-DIMETHOXYPHENOL, 92.0%, 2g

8-Bromo-indolizine, 95%, 1g

5-Methyl-[1,4]diazepane, 95.0%, 100mg